Abstract: An underground networking tunnel may be installed at a data center construction site prior to completion of a data center being constructed at the data center construction site. Networking equipment in the underground networking tunnel may be configured and commissioned concurrently with construction of the data center. Also data center power and cooling systems may service the underground networking subsequent to construction of a data center above the underground networking tunnel.

Abstract: Disclosed is a quick-donning mini-jacket with matching left and right segments, either one of which may independently be used to cover and/or protect a baseball pitcher's throwing arm. Upon insertion of the pitcher's arm into either segment, the wearer may experience a snug, comfortable fit of the garment about the perimeter of the wearer's shoulder and arm, by virtue of an inner elastic band. Should the inner elastic band be insufficient for a close and comfortable fit, an adjustment strap is provided, typically of a hook-and-felt fastening mechanism. By adjusting tightness of the strap, the tensile force about the shoulder joint may be increased a comfortable amount. In this manner, a pitcher's arm can be kept warm, relaxed, and relatively free from muscle tightening or tension that might result from a just-completed pitching session.

Abstract: The invention described herein relates to: the use of an effective inhibitor of a bacterial ?-amylase and/or ?-glucosidase in the manufacture of a composition for the treatment of acidosis; a method of treatment of rumen acidosis which comprises administration of an effective amount of an effective inhibitor of a bacterial ?-amylase and/or ?-glucosidase to a ruminant; a formulation suitable for the treatment of acidosis in an animal which comprises an effective inhibitor of a bacterial ?-amylase and/or ?-glucosidase in admixture with a suitable excipient, diluent or carrier selected with regard to the intended route of administration and standard pharmaceutical/veterinary/farming practice; screening methods useful in the identification of a suitable inhibitor of a bacterial ?-amylase and/or ?-glucosidase for the treatment of acidosis in a ruminant; a process for improving ruminant milk quality and/or quantity which comprises treatment of a ruminant with an effective amount of an inhibitor of bacterial ?-amyla

Abstract: Compounds of formula (I), their salts and prodrugs thereof, where the substituents are as defined herein are disclosed as opiate binding agents useful in the treatment of opiate-mediated conditions. Also described are processes for making such substances.

Abstract: The invention described herein relates to: the use of an effective inhibitor of a bacterial ?-amylase and/or ?-glucosidase in the manufacture of a composition for the treatment of rumen acidosis; a method of treatment of rumen acidosis which comprises administration of an effective amount of an effective inhibitor of a bacterial ?-amylase and/or ?-glucosidase to a ruminant; a formulation suitable for the treatment of rumen acidosis in an animal which comprises an effective inhibitor of a bacterial ?-amylase and/or ?-glucosidase in admixture with a suitable excipient, diluent or carrier selected with regard to the intended route of administration and standard pharmaceutical/veterinary/farming practice; screening methods useful in the identification of a suitable inhibitor of a bacterial ?-amylase and/or ?-glucosidase for the treatment of acidosis in a ruminant; a process for improving ruminant milk quality and/or quantity which comprises treatment of a ruminant with an effective amount of an inhibitor of bacte

Abstract: Compounds of formulae (IA) and (IB): wherein R1, R2, R3, Ar1 and X are as defined above, are endothelin antagonists. The compounds are therefore useful in the treatment of a variety of conditions mediated by endothelin, such as restenosis, renal failure and systemic and pulmonary hypertension.

Abstract: Compounds of formula (I) wherein the substituents are as defined herein, are antiparasitic agents.

Abstract: The invention described herein relates to: the use of an effective inhibitor of a bacterial &agr;-amylase and/or &agr;-glucosidase in the manufacture of a composition for the treatment of acidosis; a method of treatment of rumen acidosis which comprises administration of an effective amount of an effective inhibitor of a bacterial &agr;-amylase and/or &agr;-glucosidase to a ruminant; a formulation suitable for the treatment of acidosis in an animal which comprises an effective inhibitor of a bacterial &agr;-amylase and/or &agr;-glucosidase in admixture with a suitable excipient, diluent or carrier selected with regard to the intended route of administration and standard pharmaceutical/veterinary/farming practice; screening methods useful in the identification of a suitable inhibitor of a bacterial &agr;-amylase and/or &agr;-glucosidase for the treatment of acidosis in a ruminant; a process for improving ruminant milk quality and/or quantity which comprises treatment of a ruminant with an effective amount of a

Abstract: Compounds of formula (I), pharmaceutical formulations thereof and the use of such compounds for treating endothelin mediated diseases or conditions are described herein. The compounds of the present invention have affinity for endothelin receptors, are selective for ETA over ETB, and thus are useful in the treatment of conditions mediated by endothelin.

Abstract: Compounds of formulae (IA) and (IB): 1

Abstract: Compounds of formula I, 1

Abstract: Compounds of formula (I) 1

Abstract: Compounds of formulae (IA) and (IB): wherein R1, R2, R3, Ar1 and X are as defined above, are endothelin antagonists. The compounds are therefore useful in the treatment of a variety of conditions mediated by endothelin, such as restenosis, renal failure and systemic and pulmonary hypertension.

Abstract: The invention described herein relates to: the use of an effective inhibitor of a bacterial &agr;-amylase and/or &agr;-glucosidase in the manufacture of a composition for the treatment of acidosis; a method of treatment of rumen acidosis which comprises administration of an effective amount of an effective inhibitor of a bacterial &agr;-amylase and/or &agr;-glucosidase to a ruminant; a formulation suitable for the treatment of acidosis in an animal which comprises an effective inhibitor of a bacterial &agr;-amylase and/or &agr;-glucosidase in admixture with a suitable excipient, diluent or carrier selected with regard to the intended route of administration and standard pharmaceutical/veterinary/farming practice; screening methods useful in the identification of a suitable inhibitor of a bacterial &agr;-amylase and/or &agr;-glucosidase for the treatment of acidosis in a ruminant; a process for improving ruminant milk quality and/or quantity which comprises treatment of a ruminant with an effective amount of a

Abstract: Compounds of formula (I) wherein the substituents are as defined herein, are antiparasitic agents.

Abstract: Compounds of formula (I), their salts and prodrugs thereof, where the substituents are as defined herein are disclosed as opiate binding agents useful in the treatment of opiate-mediated conditions. Also described are processes for making such substances.

Abstract: Compounds of formula (I): 1

Abstract: An optimizing object code translation system and method perform dynamic compilation and translation of a target object code on a source operating system while performing optimization. Compilation and optimization of the target code is dynamically executed in real time. A compiler performs analysis and optimizations that improve emulation relative to template-based translation and interpretation such that a host processor which processes larger order instructions, such as 32-bit instructions, may emulate a target processor which processes smaller order instructions, such as 16-bit and 8-bit instructions. The optimizing object code translator does not require knowledge of a static program flow graph or memory locations of target instructions prior to run time. In addition, the optimizing object code translator does not require knowledge of the location of all join points into the target object code prior to execution. During program execution, a translator records branch operations.

Abstract: An optimizing object code translation system and method perform dynamic compilation and translation of a target object code on a source operating system while performing optimization. Compilation and optimization of the target code is dynamically executed in real time. A compiler performs analysis and optimizations that improve emulation relative to template-based translation and interpretation such that a host processor which processes larger order instructions, such as 32-bit instructions, may emulate a target processor which processes smaller order instructions, such as 16-bit and 8-bit instructions. The optimizing object code translator does not require knowledge of a static program flow graph or memory locations of target instructions prior to run time. In addition, the optimizing object code translator does not require knowledge of the location of all join points into the target object code prior to execution. During program execution, a translator records branch operations.

Abstract: Compounds of formula (I), their salts and prodrugs thereof, where the substituents are as defined herein are disclosed as opiate binding agents useful in the treatment of opiate-mediated conditions. Also described are processes for making such substances.